Limit for sensitivity analysis | |||
---|---|---|---|
Parameter | Baseline value | Lower | Upper |
Prevalence of class I/II outcomes | 0.267 | 0.202 | 0.332 |
Sensitivity of VEM/MRI for class I/II outcomes | 1.0 | 0.845 | 1.0 |
Specificity of VEM/MRI for class I/II outcomes | 0.705 | 0.581 | 0.804 |
Proportion of VEM/MRI indeterminate | 0.523 | 0.449 | 0.597 |
Prevalence of class I/II outcomes if VEM/MRI indeterminate | 0.278 | 0.196 | 0.378 |
Sensitivity of PET for class I/II outcomes if VEM/MRI indeterminate | 0.96 | 0.805 | 0.993 |
Specificity of PET for class I/II outcomes if VEM/MRI indeterminate | 0.246 | 0.158 | 0.363 |
Sensitivity of ictal SPECT for class I/II outcomes if VEM/MRI indeterminate | 0.783* | 0.664* | 0.869* |
Specificity of ictal SPECT for class I/II outcomes if VEM/MRI indeterminate | 0.471* | 0.262* | 0.691* |
Cost of VEM | $4,110 | NA | NA |
Cost of MRI | $600 | NA | NA |
Cost of ictal SPECT | $5,310 | NA | NA |
Cost of PET | $918 | NA | NA |
Cost of surgery | $25,691 | NA | NA |
Cost savings after class I/II outcome | $440,000 | $0 | $700,000 |
↵* Data are based on Won et al. (36).
NA = not applied.